MoneyWorks4Me

Dr Reddys Laboratories informs about press release

19 Apr 2016 Evaluate

Dr Reddys Laboratories has informed about a Press Release dated April 19, 2016 titled ‘ZEMBRACE SymTouch (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the US’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..